1. Biology

Ubiquitin-SUMO tag-team wrestles acute promyelocytic leukemia

Written by Posted on Less than 0 min read

In this issue, Jaffray and colleagues (https://doi.org/10.1083/jcb.202407133) detail the molecular machinery required to degrade the oncogene PML in response to arsenic treatment. Different posttranslational modifiers team up: ubiquitin, SUMO1, and -2/3, linked by the SUMO-targeted ubiquitin ligases TOPORS and RNF4.

Member since

More from Admin

TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus
  1. Pharmaceuticals and Drug Development

TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus

By Elana Gotkine HealthDay Reporter FRIDAY, Oct. 27, 2023 — For patients with severe aortic stenosis (AS) and small aortic annulus (SAA), valve hemodynamic results are comparable with use of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR), according to a study published online Oct. 26 in Circulation to coincide with the […]
Written by
  1. Nonclinical

Breaking Stereotypes: Flourishing in Nonclinical Positions as Healthcare Professionals

Breaking Stereotypes: Flourishing in Nonclinical Positions as Healthcare Professionals In the healthcare industry, the perception has long been that healthcare professionals solely operate in clinical environments. However, breaking stereotypes has become a crucial aspect of modern healthcare, as professionals increasingly realize the potential of nonclinical positions for career growth and making a meaningful impact. These […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Secret to crocodylian longevity | ScienceDaily

Researchers examined teeth and skulls of 99 extinct crocodylomorph species and 20 living crocodylian species to reconstruct their dietary ecology and identify characteristics that helped some groups persist through two mass extinctions. They discovered that one secret tocrocodylian longevity is their remarkably flexible lifestyles, both in what they eat and the habitat in which they […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Blood test eases diagnosis of invasive mold disease

For people with weakened immune systems, common molds lurking in the environment — in the soil, along damp walls or on a forgotten apple — can cause dangerous infections deep inside the body. These invasive mold infections can quickly become fatal without treatment, yet they are difficult to diagnose without invasive procedures such as a […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Why elephants never forget but fleas have, well, the attention span of a flea

Researchers at the Complexity Science Hub and Santa Fe Institute have developed a model to calculate how quickly or slowly an organism should ideally learn in its surroundings. An organism’s ideal learning rate depends on the pace of environmental change and its life cycle, they say. Every day, we wake to a world that is […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Do smells prime our gut to fight off infection?

Many organisms react to the smell of deadly pathogens by reflexively avoiding them. But a recent study from the University of California, Berkeley, shows that the nematode C. elegans also reacts to the odor of pathogenic bacteria by preparing its intestinal cells to withstand a potential onslaught. As with humans, nematodes’ guts are a common […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

How a critical enzyme keeps potentially dangerous genes in check

You may have heard of the fantastic-sounding “dark side of the genome.” This poorly studied fraction of DNA, known as heterochromatin, makes up around half of your genetic material, and scientists are now starting to unravel its role in your cells. For more than 50 years, scientists have puzzled over the genetic material contained in […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

A plant you’ve never heard of can do what scientists once thought impossible

About 3.7 billion years ago, a string of naturally occurring amino — the same kind that astronomers have found in meteorites and just recently in a stellar nursery near the center of the Milky Way Galaxy — reacted with a naturally occurring catalyst and began the fateful process of self-assembled replication. One of the most […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-line Treatment for Upper GI Cancers

Preliminary data from Arm A1 of the Phase 2 EDGE-Gastric study showed promising ORR and six-month PFS results, irrespective of PD-L1 expression Domvanalimab is the only Fc-silent anti-TIGIT antibody in Phase 3 for upper GI adenocarcinomas and has the potential to be first to market for these cancers FOSTER CITY, Calif., & […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Bristol Myers Squibb Announces U.S. FDA Breakthrough Therapy Designation for Investigational LPA1 Antagonist for Progressive Pulmonary Fibrosis

PRINCETON, N.J. Oct 24, 2023 — Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for BMS-986278, a potential first-in-class, oral, lysophosphatidic acid receptor 1 (LPA1) antagonist, for the treatment of progressive pulmonary fibrosis (PPF), a devastating, life-threatening illness. Currently, there is only one […]
Written by
  1. Clinical

Repurposed Drug Fenoprofen Exhibits Promise Towards Endometriosis-Associated Ache in Animal Mannequin

March 18, 2024 — Fenoprofen, a nonsteroidal anti-inflammatory drug (NSAID), efficiently alleviated ache and irritation in a rodent mannequin of endometriosis, in response to researchers funded by the Nationwide Institutes of Well being (NIH). They selected the drug after utilizing a pc algorithm to guage practically 1,300 current compounds for his or her skill to […]
Written by
  1. Clinical

Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity

CRANBURY, N.J., June 12, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the initiation of a Phase 2 clinical study of bremelanotide for the treatment of obesity. The clinical study will evaluate the safety and efficacy of bremelanotide, a […]
Written by
  1. Clinical

New Research Reveals Novel Neuroprotective Drug Candidate Meets Main Endpoint in Sufferers with Gentle to Average Alzheimer’s Illness

NEW YORK, Could 17, 2024. A examine revealed in the present day in Nature Drugs discovered {that a} novel neuroprotective drug candidate, LM11A-31, was secure and well-tolerated following dosing for 26 weeks in sufferers with gentle to reasonable Alzheimer’s illness. LM11A-31 additionally slowed the development of a number of spinal fluid and imaging biomarkers. These […]
Written by
  1. Clinical

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 Sirnaomics Ltd. (the “Company”, together with its subsidiaries, the “Group” or “Sirnaomics”; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group has completed STP707 Phase I clinical study with strong safety profile and […]
Written by
  1. Biology

Study identifies biomarker that could predict whether colon cancer patients

MIAMI, FLORIDA (July 25, 2024) – Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following surgery. However, clinical trials have shown that this treatment doesn’t improve the chances of survival for every patient. A study published July 25 in Cell Reports Medicine identifies and validates a 10-gene biomarker that […]
Written by
  1. Biology

The new power for soft

In the dynamic landscape of intelligent technology, electrically powered artificial muscle fibers (EAMFs) are emerging as a revolutionary power source for advanced robotics and wearable devices. Renowned for their exceptional mechanical properties, integration flexibility, and functional versatility, EAMFs are at the forefront of cutting-edge innovation. A recent review article titled “Emerging Innovations in Electrically Powered […]
Written by
  1. Biology

A cortical pool of LIN-5 (NuMA) controls cytokinetic furrow formation and cytokinesis completion

In animal cells, cleavage furrow formation is controlled by localized activation of the GTPase RhoA at the equatorial membrane using cues transmitted from the spindle. Here, we explore the function of LIN-5, a well-studied protein known for its role in aster separation and spindle positioning in cleavage furrow formation. We show that the cortical pool […]
Written by
  1. Blog

Empowering Pharma & Life Sciences Innovation with PointCross Life Sciences

In the dynamic landscape of drug discovery, PointCross Life Sciences is at the forefront, empowering tomorrow’s innovations one data-driven solution at a time. Recognized as one of the “10 Most Recommended Pharma & Life Sciences Technology Companies – 2023” by CIO Insider India, the company’s flagship product, Xbiom, is designed to meet the challenges of […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Ubiquitin-SUMO tag-team wrestles acute promyelocytic leukemia

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.